Recent Updates

Modified on: 
Jun 22, 2020
National COVID-19 Impact Data Dashboard 

A national organ donation and transplantation COVID-19 impact dashboard was developed in response to the COVID-19 pandemic. It is intended to help the community better understand, in near real time, the impact the COVID-19 crisis has had, either directly or indirectly on organ donation and transplantation in Canada and by extension, what impact these changes have had on potential donors and transplant candidates. 

Organs and Tissues
Modified on: 
Jun 22, 2020

NOTE: This information reflects evidence available at the time of publication.

1.  Are health professionals at risk of SARS-CoV-2 infection when handling blood products from Canadian Blood Services?

Last updated:  June 19, 2020

Transfusion
Modified on: 
Jun 22, 2020
Organs and Tissues
Modified on: 
Jun 22, 2020

Organs and Tissues
Modified on: 
Jun 22, 2020

Highly Sensitized Patient Program

Organs and Tissues
Modified on: 
Jun 19, 2020

Welcome to the home of the NHLAAC Journal Club

Starting in November 2019, the NHLAAC committee conducted its first ABHI accredited Journal Club presentation with the goal of providing a venue for Canadian HLA professionals to continue their education, knowledge sharing, and receive ABHI CE credits.

Organs and Tissues
Modified on: 
Jun 15, 2020

This national organ donation and transplantation COVID-19 impact dashboard was developed in response to the COVID-19 pandemic and is intended to help the community better understand, in near real time, the impact the COVID-19 crisis has had, either directly or indirectly on organ donation and transplantation practices in Canada and by extension, what impact these changes have had on potential donors and transplant candidates.

Organs and Tissues
Modified on: 
Jun 9, 2020

Report and recommendations

  • Severe brain injury to neurological determination of death: A Canadian forum (October 2003) PDF

Journal Publication

Organs and Tissues
Modified on: 
Jun 9, 2020

Key points

  • Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an immune-mediated cause of thrombocytopenia in neonates due to maternal anti-human platelet antigen (HPA) antibodies, most commonly anti-HPA-1a.
  • Intracranial hemorrhage (ICH) is a serious complication of FNAIT and is estimated to affect 1 in 10,000 live births.
  • Diagnostic testing for FNAIT includes three main steps:
    • Maternal anti-HPA antibody screening and identification
    • HPA genotyping of mother, father and/or neonate
    • Confirmation of antibody specificity and reactivity with the monoclonal antibody immobilization of platelet antigens (MAIPA) assay
  • HPA-matched platelets should be given to a neonate with FNAIT if immediately available, otherwise unmatched units (random pooled platelets) should be provided until matched platelets can be obtained.
Transfusion
Modified on: 
Jun 3, 2020

Health care professionals in donation and transplantation are invited to attend a series of webinars focusing on psychological first aid, grief and loss, and moral distress, within the context of the COVID-19 pandemic. 

A severe mass event like this pandemic can cause the general public and those affected by COVID-19, including health care workers, to be mentally impacted. Psychological First Aid is an intervention method that can help people in distress during these challenging times.

Organs and Tissues

Pages